‘From an equipment provider’s perspective, the European cannabis sector is growing rapidly…’
Speaking on From Genetics to GMP: Elevating European Cultivation
Rui Soares is the founder and CEO of Paralab, a dynamic and innovative manufacturer and supplier of advanced technology for cannabis postharvest and cannabinoid extraction and purification. Paralab operates across Europe, Thailand, Australia, and Latin America.
With over 32 years of experience serving the highly regulated European pharmaceutical market, Paralab entered the medical cannabis arena in 2018 by offering EU-GMP compliant solutions for controlling bioburden in cannabis production, bucking, trimming, sorting, drying, decontamination, packaging, milling, extraction, winterization, filtration, decarboxylation, wiped film distillation, crystallization, and chromatography.
Paralab is ISO 9001:2015 certified, has an EU-GMP certified laboratory for human medicinal products and human investigational medicinal products, and is also licensed to perform R&D activities with cannabis products.
On the London 2026 programme
- Day 2 · Main Stage · 12:10 pmBeyond Flower: Is Europe's Medical Cannabis Market Turning Pharmaceutical?